Enzyme Linked Immunosorbent Assay (ELISA) Development Services
Robust and proven technology, enzyme linked immunosorbent assays (ELISAs) can deliver quantitative antibody-based measurement of any target for which there is a sensitive and specific binding reagent, such as an antibody or aptamer. At Precision, we offer ELISA development services to support pre-clinical through phase 3 studies, including assay development or transfer, validation, and implementation.
ELISA Assays and Precision for Medicine’s Approach
Multiple platforms enable a broad range of enzyme linked immunosorbent assay (ELISA) applications
ELISA development service capabilities
- Assay development or transfer (custom assays or commercial kits), validation, and implementation
- Multiple platforms: colorimetric, fluorescent, luminescent, MSD
- Support pre-clinical through phase 3 studies
- ISO/GCP/GLP/CAP/CLIA regulated assays
ELISA test applications
- PK studies
- Cytokine analysis
- Immunogenicity (ADA, TAb) assays
Illustration of types of ELISA assays
The Precision advantage: integrating biomarker and clinical trial data
To help researchers understand and interpret biomarker assay data in the context of other assays, such as enzyme linked immunosorbent assays (ELISAs), as well as the clinical trial data, Precision manages all assay data using our proprietary QuartzBio® Translational Informatics platform.
Global reach, multi-site support for ELISA development
Our ELISA services support pre-clinical and clinical research, including multi-site studies, conducted anywhere in the world.
Working with Precision
Precision’s specialty lab scientists take a collaborative and consultative approach to projects and can provide recommendations on biomarker assay strategies and implementation. Services can be provided individually or as part of a comprehensive therapeutic development package including biomarker assays and clinical trials.
Luminex is useful when multiplexed measurements at high sensitivity, even in complex matrices, are needed. We generally utilize the Luminex platform in early phase studies profiling cytokines and other analytes.
MesoScale Discovery (MSD) Assays
Measure a range of analytes in complex samples matrices consistently and at high sensitivity with our MSD assay capabilities. Applications include ADA, NAb, and TAb assays, PK assays, and more.
Precision leverages multiple approaches for the development of neutralizing antibody assays (NAb) and total antibody (TAb) assays including ELISA, MesoScale, and Biacore. We have also successfully developed these and other assays into companion diagnostics.